Class II · Moderate risk
Back Pain-Off
cGMP deviations
FDA drug recalls in 2022
Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,390 recalls, newest first.
Class II · Moderate risk
MidNite Sleep Health
cGMP deviations
Class II · Moderate risk
Class II · Moderate risk
Ephedrine Plus
cGMP deviations
Class II · Moderate risk
DBI 357 Super Magnum Quick Energy Stimulant
cGMP deviations
Class II · Moderate risk
Cystex Urinary Pan Relief
cGMP deviations
Class II · Moderate risk
Legatrin PM Pain Reliever/Sleep Aid
cGMP deviations
Class II · Moderate risk
Extra Strength
cGMP deviations
Class II · Moderate risk
Chloresin
cGMP deviations
Class II · Moderate risk
Maximum Strength Non Aspirin Pain Reliever/Fever Reducer
cGMP deviations
Class II · Moderate risk
AERO TAB Cold Relief
cGMP deviations
Class II · Moderate risk
Class II · Moderate risk
Nasal & Sinus Decongestant
cGMP deviations
Class II · Moderate risk
Proctofoam HC
cGMP deficiencies
Class III · Low risk
Bortezomib
Failed stability specifications
Class III · Low risk
Azacitidine
Failed stability specifications
Class III · Low risk
Azacitidine
Failed stability specifications
Class II · Moderate risk
Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
Class II · Moderate risk
Moxifloxacin Ophthalmic Solution
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Lexette (halobetasol propionate)
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II · Moderate risk
Metoprolol Succinate Extended-Release Tablets
Failed Dissolution Specifications.
Class II · Moderate risk
Lung Cleaner
cGMP deviations
Class II · Moderate risk
8.4% Sodium Bicarbonate Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Tretinoin Capsules
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Class III · Low risk
Mucus Relief D
Subpotent drug